Epimede
Overview
A privately-held investment company structured as a private fund (PRICAF under Belgian law) that takes long-term positions in innovative life sciences and engineering companies. It focuses on early-stage and growth-stage technological SMEs, primarily located in Wallonia, Belgium.
Portfolio Companies
6
Website
epimede.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Wishbone Biotech | Dec 2021 | Early Funding | Co-investor |
| Imcyse | Feb 2021 | Series B Extension | Co-investor |
| Endo Tools Therapeutics | Jan 2021 | Series D | Co-investor |
| Radiomics | Nov 2021 | Series A | Lead |
| Novadip Biosciences | Sep 2015 | Series A | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Epimede based?
Epimede is headquartered in Liège.
When was Epimede founded?
Founding year information for Epimede is not publicly available.
How many portfolio companies does Epimede have?
Epimede has 6 portfolio companies in Caplight's dataset.
What are some companies in Epimede's portfolio?
Portfolio companies visible on Caplight include Wishbone Biotech, Imcyse, Endo Tools Therapeutics, Radiomics, Novadip Biosciences.
What was Epimede's most recent investment shown here?
Epimede's most recent investment in this portfolio sample was in Wishbone Biotech in 2021.
What sectors does Epimede focus on?
Epimede focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure.
What company stages does Epimede focus on?
Epimede typically invests at the Mid stage.